2.22 USD
-0.05 (-2.2%)
2.27 USD
+0.05 (+2.25%)
CHSN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 38 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of CHSN is average, but there are quite some concerns on its profitability. CHSN does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year CHSN has reported negative net income.
In the past year CHSN had a positive cash flow from operations.
In multiple years CHSN reported negative net income over the last 5 years.
Of the past 5 years CHSN 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.61%, CHSN is doing worse than 68.42% of the companies in the same industry.
CHSN has a worse Return On Equity (-1.29%) than 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.61% | ||
| ROE | -1.29% | ||
| ROIC | N/A |
ROA(3y)-0.94%
ROA(5y)-0.31%
ROE(3y)-34.98%
ROE(5y)-18.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CHSN's Profit Margin has declined in the last couple of years.
CHSN has a Gross Margin of 40.95%. This is amongst the best in the industry. CHSN outperforms 89.47% of its industry peers.
CHSN's Gross Margin has declined in the last couple of years.
CHSN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.95% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.12%
PM growth 5Y-11.29%
GM growth 3Y-5.77%
GM growth 5Y-5.73%
2. Health
2.1 Basic Checks
CHSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CHSN has been reduced compared to 1 year ago.
The number of shares outstanding for CHSN has been reduced compared to 5 years ago.
The debt/assets ratio for CHSN has been reduced compared to a year ago.
2.2 Solvency
CHSN has an Altman-Z score of 0.68. This is a bad value and indicates that CHSN is not financially healthy and even has some risk of bankruptcy.
CHSN's Altman-Z score of 0.68 is on the low side compared to the rest of the industry. CHSN is outperformed by 86.84% of its industry peers.
CHSN has a debt to FCF ratio of 3.29. This is a good value and a sign of high solvency as CHSN would need 3.29 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.29, CHSN is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
A Debt/Equity ratio of 0.19 indicates that CHSN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.19, CHSN is in the better half of the industry, outperforming 76.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 3.29 | ||
| Altman-Z | 0.68 |
ROIC/WACCN/A
WACC6.69%
2.3 Liquidity
A Current Ratio of 2.00 indicates that CHSN has no problem at all paying its short term obligations.
The Current ratio of CHSN (2.00) is better than 84.21% of its industry peers.
A Quick Ratio of 1.95 indicates that CHSN should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.95, CHSN belongs to the best of the industry, outperforming 92.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2 | ||
| Quick Ratio | 1.95 |
3. Growth
3.1 Past
CHSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.11%, which is quite impressive.
CHSN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.68% yearly.
CHSN shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.20%.
Measured over the past years, CHSN shows a small growth in Revenue. The Revenue has been growing by 7.70% on average per year.
EPS 1Y (TTM)100.11%
EPS 3Y3.84%
EPS 5Y-9.68%
EPS Q2Q%-2003.98%
Revenue 1Y (TTM)21.2%
Revenue growth 3Y7.46%
Revenue growth 5Y7.7%
Sales Q2Q%15.19%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHSN indicates a rather cheap valuation: CHSN is cheaper than 97.37% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.71 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
CHSN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
2.22
-0.05 (-2.2%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)
Earnings (Next)
Inst Owners1.13%
Inst Owner Change0%
Ins Owners0.54%
Ins Owner ChangeN/A
Market Cap2.53M
Revenue(TTM)19.37M
Net Income(TTM)-315.90K
AnalystsN/A
Price TargetN/A
Short Float %4.7%
Short Ratio1.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.13 | ||
| P/FCF | 1.71 | ||
| P/OCF | 1.08 | ||
| P/B | 0.1 | ||
| P/tB | 0.1 | ||
| EV/EBITDA | N/A |
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.3
FCFY58.56%
OCF(TTM)2.05
OCFY92.52%
SpS16.99
BVpS21.53
TBVpS21.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.61% | ||
| ROE | -1.29% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.95% | ||
| FCFM | 7.65% |
ROA(3y)-0.94%
ROA(5y)-0.31%
ROE(3y)-34.98%
ROE(5y)-18.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y6.12%
PM growth 5Y-11.29%
GM growth 3Y-5.77%
GM growth 5Y-5.73%
F-Score3
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 3.29 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 111.45% | ||
| Cap/Sales | 4.44% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2 | ||
| Quick Ratio | 1.95 | ||
| Altman-Z | 0.68 |
F-Score3
WACC6.69%
ROIC/WACCN/A
Cap/Depr(3y)101.58%
Cap/Depr(5y)151.1%
Cap/Sales(3y)5.01%
Cap/Sales(5y)6.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.11%
EPS 3Y3.84%
EPS 5Y-9.68%
EPS Q2Q%-2003.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.2%
Revenue growth 3Y7.46%
Revenue growth 5Y7.7%
Sales Q2Q%15.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y37.23%
FCF growth 3YN/A
FCF growth 5Y30.19%
OCF growth 1Y54.05%
OCF growth 3Y25.73%
OCF growth 5Y19.86%
CHANSON INTERNATIONAL HOLD-A / CHSN FAQ
What is the ChartMill fundamental rating of CHANSON INTERNATIONAL HOLD-A (CHSN) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSN.
What is the valuation status of CHANSON INTERNATIONAL HOLD-A (CHSN) stock?
ChartMill assigns a valuation rating of 2 / 10 to CHANSON INTERNATIONAL HOLD-A (CHSN). This can be considered as Overvalued.
How profitable is CHANSON INTERNATIONAL HOLD-A (CHSN) stock?
CHANSON INTERNATIONAL HOLD-A (CHSN) has a profitability rating of 2 / 10.
What is the financial health of CHANSON INTERNATIONAL HOLD-A (CHSN) stock?
The financial health rating of CHANSON INTERNATIONAL HOLD-A (CHSN) is 6 / 10.